Business and Basis of Presentation - Schedule of Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended		9 Months Ended
	Dec. 21, 2023	Apr. 03, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss available to common stockholders			$ (10,001)	$ (10,460)	$ (24,577)	$ (21,808)
Deemed dividend related to warrant modification and issuance of Inducement Warrants (Note 8)			(2,721)	0	(8,333)	0
Net loss attributable to common stockholders			(12,722)	(10,460)	(32,910)	(21,808)
Net loss attributable to common stockholders			$ (12,722)	$ (10,460)	$ (32,910)	$ (21,808)
Weighted average common shares outstanding - basic (in shares)			62,183,843	56,739,450	61,458,945	55,926,828
Weighted average common shares outstanding - diluted (in shares)			62,183,843	56,739,450	61,458,945	55,926,828
Net loss per share - basic (in usd per share)			$ (0.20)	$ (0.18)	$ (0.54)	$ (0.38)
Net loss per share - diluted (in usd per share)			$ (0.20)	$ (0.18)	$ (0.54)	$ (0.38)
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Deemed dividend related to warrant modification and issuance of Inducement Warrants (Note 8)			$ (837)	$ 0	$ (1,590)	$ 0
Inducement Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Deemed dividend related to warrant modification and issuance of Inducement Warrants (Note 8)	$ (1,900)	$ (4,900)	$ (1,884)	$ 0	$ (6,743)	$ 0